What Happened? Shares of solar tracking systems manufacturer Array (NASDAQ:ARRY) fell 4.3% in the morning session after the stock pulled back from a recent 52-week high, appearing to give back some of ...

Array allegedly sold credit data to shady end-users and listed an employee's dad's tea shop as a growing customer, a former exec alleged.

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Jack Newsham Every time Jack publishes a story, you’ll get an alert straight to your inbox!

Array BioPharma has been weighing a potential sale for years, and now that it’s inked an $11.4 billion deal with Pfizer, the company’s top execs stand to reap some hefty payouts. Really hefty, in the ...

Array Technologies is seeing easing regulatory uncertainty, rebounding demand, and stabilizing pricing. Learn why ARRY stock is a Buy.

What Happened? Shares of solar tracking systems manufacturer Array (NASDAQ:ARRY) jumped 6.9% in the afternoon session after ...